JP Morgan Chase’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Hold
0
7773
2024
Q3
Hold
0
7719
2023
Q2
Hold
0
7386
2023
Q1
Hold
0
7288
2022
Q4
Hold
0
7058
2022
Q3
Hold
0
6910
2022
Q2
Hold
0
6942
2022
Q1
Hold
0
7084
2021
Q4
Hold
0
7011
2021
Q3
Hold
0
6852
2021
Q2
Hold
0
6654
2021
Q1
Hold
0
6407
2020
Q4
Hold
0
5976
2020
Q3
Sell
-6
Closed -$5.72K 5828
2020
Q2
$4K Sell
6
-159
-96% -$71.3K ﹤0.01% 5214
2020
Q1
$55K Buy
165
+156
+1,733% +$61.5K ﹤0.01% 4701
2019
Q4
$8K Hold
9
﹤0.01% 5424
2019
Q3
$13K Buy
9
+2
+29% +$3.21K ﹤0.01% 5478
2019
Q2
$15K Buy
+7
New +$14.2K ﹤0.01% 5501

Other funds holding YCBD

JP Morgan Chase's YCBD Position: Q4 2024 in Review

JP Morgan Chase held its cbdMD (YCBD) position steady in Q4 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7773.

JP Morgan Chase first reported a position in YCBD in Q2 2019 and has held it in 5 quarters since. The position peaked at $55K in Q1 2020. 16 funds tracked by Wall St. Rank hold YCBD as of Q4 2024.

  • JP Morgan Chase held 0 shares of cbdMD worth $0 as of Q4 2024.
  • JP Morgan Chase left its cbdMD share count unchanged in Q4 2024.
  • cbdMD made up ﹤0.01% of JP Morgan Chase's portfolio in Q4 2024, its #7773 holding.
  • JP Morgan Chase first reported a position in cbdMD in Q2 2019 and has held it in 5 quarters since.
  • JP Morgan Chase's cbdMD position peaked at $55K in Q1 2020.
  • 16 funds tracked by Wall St. Rank held cbdMD as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.